health ๐ฉบ Chinese scientists create smart probiotic for diabetes
Researchers from East China Normal University unveiled a new 'sense-and-respond' probiotic drug called GIFT for diabetes treatment. This engineered oral probiotic can live in the intestine and autonomously secrete glucose-lowering hormones based on real-time blood sugar. The findings were published in the journal Nature on August 12, 2026. This method shifts care from injections to oral regulation, offering a safer option for the 530 million global adults with diabetes. GIFT positions China at the forefront of smart living drugs for metabolic diseases. ๐ฉบ